Maiwald
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Maiwald Intellectual PropertyMarco Stief of Maiwald argues that the District Court of The Hague missed an opportunity to clarify the uncertainty surrounding the term ‘first authorisation’ in Article 3(d) of the SPC Regulation in a recent judgment -
Sponsored by Maiwald Intellectual PropertyFabian Kiendl and Christian Schäflein of Maiwald examine how AI engineering can yield patentable inventions and consider the protection of such solutions in automotive technology under the European Patent Convention
-
Sponsored by Maiwald Intellectual PropertyKerstin Wolff and Tobias Matschke of Maiwald Intellectual Property examine a landmark Unified Patent Court decision on second medical use claims and compare it with Germany’s established approach to ‘skinny label’ products
-
Sponsored by Maiwald Intellectual PropertyKerstin Wolff of Maiwald Intellectual Property examines the EU’s winding path towards the regulation of new genomic techniques, with a proposed patent ban remaining a key source of contention
-
Sponsored by Maiwald Intellectual PropertySenior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
-
Sponsored by Maiwald Intellectual PropertyAnnelie Wünsche of Maiwald Intellectual Property summarises the EU’s proposed update to the supplementary protection certificate system for medicinal products, highlighting key procedural shifts, the role of the EUIPO, and ongoing debate over the most suitable examining authority
